Finding New Therapy Targets for Mast Cell Tumors
Researchers will identify new therapy targets for malignant mast cell tumors, acommon and aggressive cancer in dogs.
Researchers will identify new therapy targets for malignant mast cell tumors, acommon and aggressive cancer in dogs.
Researchers will evaluate a novel drug as a potential new treatment for immunemediated hemolytic anemia, a serious and fatal blood disorder in dogs.
Researchers will investigate how metabolic processes affect tumor growth andchemotherapy resistance in dogs with hemangiosarcoma and ways to block or disrupt these processes.
Researchers will investigate genetic mutations associated with increased risk for calcium oxalate urinary stones, a painful and common health problem in dogs.
Researchers will use genetic fingerprinting methods to track and help prevent serious antibiotic-resistant staph infection outbreaks in dogs and cats.
Researchers are evaluating the effectiveness of oral rapamycin as an adjunct, postsurgery therapy to combat cancer spread (metastasis) in client-owned dogs.
This grant supports the advanced training of two aspiring veterinary pathologists who will assist with the analysis of tissue samples collected from dogs enrolled in Morris Animal Foundation's Golden Retriever Lifetime Study.